AcariaHealth, a leading national specialty pharmacy, is proud to announce its collaboration with Madrigal Pharmaceuticals as a limited distribution specialty pharmacy partner for REZDIFFRA™ (resmetirom). Recently granted accelerated approval by the U.S. Food and Drug Administration (FDA), REZDIFFRA is a once-daily oral THR-β agonist and the first medication specifically approved for treating adults with noncirrhotic nonalcoholic steatohepatitis (NASH) who have moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in combination with diet and exercise.

As noted by the Mayo Clinic, NASH is a more severe form of nonalcoholic fatty liver disease (NAFLD). NAFLD involves excessive fat accumulation in the liver, while NASH progresses to liver inflammation and damage due to fat deposits, potentially leading to liver scarring, or cirrhosis. Both conditions are associated with factors such as genetics, obesity, insulin resistance, diabetes, and elevated blood fat levels.

In June 2023, leading global liver disease medical societies and patient groups announced new nomenclature with the goal of establishing affirmative, non-stigmatizing names and diagnoses. Nonalcoholic fatty liver disease (NAFLD) was renamed metabolic dysfunction-associated steatotic liver disease (MASLD), and nonalcoholic steatohepatitis (NASH) was renamed metabolic dysfunction-associated steatohepatitis (MASH). An overarching term, steatotic liver disease (SLD), was established to capture multiple types of liver diseases associated with fat buildup in the liver.

AcariaHealth is dedicated to making a positive impact on patient lives through empathetic and comprehensive care. We prioritize timely medication delivery, provide ongoing support, and ensure exceptional patient care throughout the treatment process. Patients and healthcare providers can depend on AcariaHealth for reliable service and dedicated support.

To refer a patient or learn more about REZDIFFRA, download the referral form. For comprehensive prescribing information, visit rezdiffra.com, and additional resources for healthcare professionals are available at rezdiffrahcp.com.

Stay updated with the latest from AcariaHealth by following us on LinkedIn for important announcements and industry updates.